glp 1 and ddp4 combination Insights into the Roles of GLP-1, DPP-4, SGLT2 at the Crossroads of Cardiovascular, Renal, and Metabolic Pathophysiology Neuroprotection by dipeptidyl-peptidase-4 inhibitors and

doi: 10.3389/fnut.2026.1809416 Received 11 February 2026 Revised 24 April 2026 Accepted 11 May 2026 Published 02 June 2026 Volume 13 - 2026 Edited by Ivana arac, University of Belgrade, Serbia Reviewed by Dbora Luana Ribeiro Pessoa, Federal University of Maranho, Brazil Jiaqi Liu, University of Texas Health Science Center at Houston, United States Updates Copyright 2026 Song, Fang, Li, Fu, He, Gao, Tian and Gao

As weve defined obesity, its a chronic condition

Government Support and Policy Initiatives Recognizing the need for accessible obesity treatments, India plans to offer incentives under the Production Linked Incentive (PLI) scheme to promote the local manufacturing of GLP-1 drugs in 2026

The moment you puncture that stopper, the clock starts ticking